×
About 4,855 results

ALLMedicine™ Cervical Intraepithelial Neoplasia Center

Research & Reviews  1,728 results

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the internat...
https://doi.org/10.1186/s12967-022-03383-x 10.1016/j.ejca.2009.07.016 10.1093/annonc/mdp471 10.1002/ijc.21955 10.3390/v10120729 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10.1136/bmj.g130 10.1016/S0140-6736(07)61450-0 10.3310/hta13510 10.1016/j.ygyno.2007.07.021 10.1016/S0140-6736(13)62218-7 10.1002/ijc.24010 10.1016/j.cmi.2020.03.033 10.1016/j.jcv.2015.10.023 10.1371/journal.pone.0210997 10.1186/s13104-018-3252-6 10.1002/ijc.28834 10.1038/sj.bjc.6606040 10.1186/s12885-018-4165-4 10.1186/1471-2407-14-207 10.1038/bjc.2015.11 10.1186/s12885-015-1804-x 10.1371/journal.pmed.0050132 10.1016/j.jcv.2013.06.041 10.1001/jama.287.16.2114 10.1002/path.1433 10.1002/sim.1213 10.1016/j.canep.2014.01.004 10.2147/IJWH.S56307 10.1200/jgo.2016.005629 10.1016/j.jcv.2018.08.006 10.1186/s12885-016-2246-9 10.1186/s12913-017-2160-0 10.1186/s12905-017-0490-z 10.1016/S1470-2045(13)70570-9 10.1136/sti.2004.011858 10.1002/sim.4780081110 10.1158/1055-9965.EPI-12-0953-T 10.1186/s12885-015-1126-z 10.1186/1471-2288-9-5 10.1016/j.cmi.2017.05.020 10.1186/s12885-015-1223-z 10.1186/s12885-016-2518-4 10.1371/journal.pone.0086835 10.1038/bjc.2013.22 10.1054/bjoc.2000.1375 10.1158/1055-9965.EPI-20-1538
Journal of Translational Medicine; Avian A, Clemente N et. al.

May 18th, 2022 - According to international guidelines, Human Papillomavirus (HPV) DNA tests represent a valid alternative to Pap Test for primary cervical cancer screening, provided that they guarantee balanced clinical sensitivity and specificity for cervical in...

Addition of digital VIA/VILI to conventional naked-eye examination for triage of HPV-po...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098068
PloS One; Dufeil E, Kenfack B et. al.

May 14th, 2022 - World Health Organization guidelines for cervical cancer screening recommend HPV testing followed by visual inspection with acetic acid (VIA) for triage if HPV positive. In order to improve visual assessment and identification of cervical intraepi...

Does mode of delivery impact the course of cervical dysplasia in pregnancy? A review of...
https://doi.org/10.1016/j.ejogrb.2022.05.002
European Journal of Obstetrics, Gynecology, and Reproduct... Bracic T, Reich O et. al.

May 14th, 2022 - The prevalence of cervical intraepithelial neoplasia (CIN) in pregnancy is about 1%. The aim of this study was to analyze the regression, persistence and progression rates of cervical dysplasia in pregnancy and the impact of delivery mode. In this...

Cervical Cancer Treatment & Management
http://emedicine.medscape.com/article/253513-treatment

May 13th, 2022 - Approach Considerations Intravaginal application of 5% 5-fluorouracil (5-FU) was found to be an effective treatment for cervical intraepithelial neoplasia (CIN) 2 in a prospective, nonblinded, randomized controlled study of 60 women. [64, 65] At 6...

Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With...
https://doi.org/10.1200/JCO.21.02433
Journal of Clinical Oncology : Official Journal of the Am... Kremer WW, Dick S et. al.

May 6th, 2022 - Cervical screening can prevent cancer by detection and treatment of cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3). Screening also results in considerable overtreatment because many CIN2/3 lesions show spontaneous regression when left un...

see more →

Guidelines  10 results

ASCCP Risk-Based Colposcopy Recommendations Applied in Thai Women With Atypical Squamou...
https://doi.org/10.1097/AOG.0000000000003982
Obstetrics and Gynecology; Phianpiset R, Ruengkhachorn I et. al.

Aug 10th, 2020 - To compare the proportion of cervical intraepithelial neoplasia (CIN) 2 or worse pathology among different risk strata according to the ASCCP when applied in women who had atypical squamous cells of undetermined significance (ASC-US) or low-grade ...

Cervical cancer screening for individuals at average risk: 2020 guideline update from t...
https://doi.org/10.3322/caac.21628
CA: a Cancer Journal for Clinicians; Fontham ETH, Wolf AMD et. al.

Jul 31st, 2020 - The American Cancer Society (ACS) recommends that individuals with a cervix initiate cervical cancer screening at age 25 years and undergo primary human papillomavirus (HPV) testing every 5 years through age 65 years (preferred); if primary HPV te...

Evaluation of guidelines for observational management of cervical intraepithelial neopl...
https://doi.org/10.1016/j.ajog.2020.02.029
American Journal of Obstetrics and Gynecology; Dempster-Rivett K, Innes CR et. al.

Feb 29th, 2020 - A high rate of regression in young women with cervical intraepithelial neoplasia grade 2 has been recorded. However, there are few prospective data by which to evaluate management guidelines. This study evaluates the American Society for Colposcop...

Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cerv...
https://doi.org/10.1007/s10147-018-1351-y
International Journal of Clinical Oncology; Ebina Y, Mikami M et. al.

Oct 7th, 2018 - The Japan Society of Gynecologic Oncology (JSGO) Guidelines 2017 for the Treatment of Uterine Cervical Cancer are for the purpose of providing standard treatment strategies for cervical cancer, indicating treatment methods currently considered app...

World Health Organization Guidelines for treatment of cervical intraepithelial neoplasi...
https://doi.org/10.1016/j.ijgo.2015.07.038
International Journal of Gynaecology and Obstetrics: the ... Santesso N, Mustafa RA et. al.

Feb 13th, 2016 - It is estimated that 1%-2% of women develop cervical intraepithelial neoplasia grade 2-3 (CIN 2-3) annually worldwide. The prevalence among women living with HIV is higher, at 10%. If left untreated, CIN 2-3 can progress to cervical cancer. WHO ha...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  50 results

5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa
https://clinicaltrials.gov/ct2/show/NCT05362955

May 5th, 2022 - This is a single arm study on the safety, feasibility, and acceptability of adjuvant, self-administered, intravaginal 5-Fluorouracil (5-FU) following treatment for high-grade cervical precancer (CIN2/3) among women living with human immunodeficien...

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)
https://clinicaltrials.gov/ct2/show/NCT04400578

Apr 7th, 2022 - Visit and assessment Schedule: Visit1 Screening: Informed Consent, Inclusion/Exclusion Criteria, Medical History, Gynecological Examination Cytology HPV Test Colposcopy Biopsy VAS (Visual analog scale) Pregnancy test Visit 2 Treatment Day with TCA...

Cervical Cancer Screening Strategies
https://clinicaltrials.gov/ct2/show/NCT05309122

Apr 4th, 2022 - This study is to investigate retrospectively the results of cervical cytology and high-risk human papillomavirus in the past 20 years recorded in Peking Union Medical College Hospital. The histological findings after cervical cancer screening were...

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
https://clinicaltrials.gov/ct2/show/NCT04098744

Mar 17th, 2022 - Eligible participants in this study are randomized to receive either artesunate or placebo vaginal inserts for the treatment of CIN2/3. Both groups receive three 5-day cycles of the respective drug, at weeks 0, 2, and 4. Dosing visits can be done ...

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
https://clinicaltrials.gov/ct2/show/NCT03196180

Feb 23rd, 2022 - PRIMARY OBJECTIVE: I. Assess feasibility, evaluated based on safety and tolerability, of a combination agent intervention (once-weekly self-administered intravaginal application of 5-fluorouracil alternating with once-weekly provider-applied imiqu...

see more →

News  151 results

Pregnancy Outcomes Improving After Treatment for High-Grade Cervical Neoplasia
https://www.medscape.com/viewarticle/968052

Feb 8th, 2022 - NEW YORK (Reuters Health) - The risk for pregnancy-related complications following treatment for grade-3 cervical intraepithelial neoplasia (CIN 3) has declined over time, thanks to advances in treatment, a new study indicates. However, women trea...

HPV Testing Plus Cytology Catches Two Times More Cervical Lesions
https://www.medscape.com/viewarticle/966373

Jan 11th, 2022 - Combining high-risk human papillomavirus (hrHPV)–based screening with cytologic triage detected two times more cases of grade 2+ cervical intraepithelial neoplasia (CIN2+) than cytology alone, according to a new study. The study, which analyzed da...

HPV Vaccinations Still Down from Pre-Pandemic Levels
https://www.medscape.com/viewarticle/964761

Dec 14th, 2021 - The Government is urging anyone eligible for the human papillomavirus (HPV) vaccine get vaccinated, as vaccination numbers are still lower than they were before the COVID pandemic. The onset of the COVID-19 pandemic in 2020 negatively impacted man...

CIN Prophylaxis: When to Intervene
https://www.onclive.com/view/cin-prophylaxis-when-to-intervene

Oct 19th, 2021 - Hope S. Rugo, MD, FASCO: It’s important for us to understand when patients are at their greatest risk for CIN [cervical intraepithelial neoplasia], which is after they start chemotherapy. That’s something our patients also want to know, in terms o...

LEEP Seems More Likely Than Cryotherapy to Clear HPV Infection in Women With HIV
https://www.medscape.com/viewarticle/956595

Aug 16th, 2021 - NEW YORK (Reuters Health) - In women with HIV, a loop electrosurgical excision procedure (LEEP) was 40% more likely than cryotherapy to clear high-risk human papillomavirus (hrHPV) in a secondary analysis of a randomized trial in Africa. The analy...

see more →